PubMed:18376396
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-104 | Sentence | denotes | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
| TextSentencer_T2 | 105-270 | Sentence | denotes | Epithelial to mesenchymal transition (EMT) facilitates tissue remodelling during embryonic development and is viewed as an essential early step in tumour metastasis. |
| TextSentencer_T3 | 271-571 | Sentence | denotes | We found that all five members of the microRNA-200 family (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) and miR-205 were markedly downregulated in cells that had undergone EMT in response to transforming growth factor (TGF)-beta or to ectopic expression of the protein tyrosine phosphatase Pez. |
| TextSentencer_T4 | 572-667 | Sentence | denotes | Enforced expression of the miR-200 family alone was sufficient to prevent TGF-beta-induced EMT. |
| TextSentencer_T5 | 668-893 | Sentence | denotes | Together, these microRNAs cooperatively regulate expression of the E-cadherin transcriptional repressors ZEB1 (also known as deltaEF1) and SIP1 (also known as ZEB2), factors previously implicated in EMT and tumour metastasis. |
| TextSentencer_T6 | 894-1007 | Sentence | denotes | Inhibition of the microRNAs was sufficient to induce EMT in a process requiring upregulation of ZEB1 and/or SIP1. |
| TextSentencer_T7 | 1008-1132 | Sentence | denotes | Conversely, ectopic expression of these microRNAs in mesenchymal cells initiated mesenchymal to epithelial transition (MET). |
| TextSentencer_T8 | 1133-1294 | Sentence | denotes | Consistent with their role in regulating EMT, expression of these microRNAs was found to be lost in invasive breast cancer cell lines with mesenchymal phenotype. |
| TextSentencer_T9 | 1295-1411 | Sentence | denotes | Expression of the miR-200 family was also lost in regions of metaplastic breast cancer specimens lacking E-cadherin. |
| TextSentencer_T10 | 1412-1515 | Sentence | denotes | These data suggest that downregulation of the microRNAs may be an important step in tumour progression. |
| T1 | 0-104 | Sentence | denotes | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
| T2 | 105-270 | Sentence | denotes | Epithelial to mesenchymal transition (EMT) facilitates tissue remodelling during embryonic development and is viewed as an essential early step in tumour metastasis. |
| T3 | 271-571 | Sentence | denotes | We found that all five members of the microRNA-200 family (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) and miR-205 were markedly downregulated in cells that had undergone EMT in response to transforming growth factor (TGF)-beta or to ectopic expression of the protein tyrosine phosphatase Pez. |
| T4 | 572-667 | Sentence | denotes | Enforced expression of the miR-200 family alone was sufficient to prevent TGF-beta-induced EMT. |
| T5 | 668-893 | Sentence | denotes | Together, these microRNAs cooperatively regulate expression of the E-cadherin transcriptional repressors ZEB1 (also known as deltaEF1) and SIP1 (also known as ZEB2), factors previously implicated in EMT and tumour metastasis. |
| T6 | 894-1007 | Sentence | denotes | Inhibition of the microRNAs was sufficient to induce EMT in a process requiring upregulation of ZEB1 and/or SIP1. |
| T7 | 1008-1132 | Sentence | denotes | Conversely, ectopic expression of these microRNAs in mesenchymal cells initiated mesenchymal to epithelial transition (MET). |
| T8 | 1133-1294 | Sentence | denotes | Consistent with their role in regulating EMT, expression of these microRNAs was found to be lost in invasive breast cancer cell lines with mesenchymal phenotype. |
| T9 | 1295-1411 | Sentence | denotes | Expression of the miR-200 family was also lost in regions of metaplastic breast cancer specimens lacking E-cadherin. |
| T10 | 1412-1515 | Sentence | denotes | These data suggest that downregulation of the microRNAs may be an important step in tumour progression. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 773-777 | gene:6935 | denotes | ZEB1 |
| T1 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T2 | 773-777 | gene:6935 | denotes | ZEB1 |
| T3 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| T4 | 793-801 | gene:6935 | denotes | deltaEF1 |
| T5 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T6 | 793-801 | gene:6935 | denotes | deltaEF1 |
| T7 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| T8 | 807-811 | gene:9351 | denotes | SIP1 |
| T9 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T10 | 807-811 | gene:9351 | denotes | SIP1 |
| T11 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| T12 | 807-811 | gene:9839 | denotes | SIP1 |
| T13 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T14 | 807-811 | gene:9839 | denotes | SIP1 |
| T15 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| T16 | 807-811 | gene:9169 | denotes | SIP1 |
| T17 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T18 | 807-811 | gene:9169 | denotes | SIP1 |
| T19 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| T20 | 807-811 | gene:8487 | denotes | SIP1 |
| T21 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T22 | 807-811 | gene:8487 | denotes | SIP1 |
| T23 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| T24 | 827-831 | gene:9839 | denotes | ZEB2 |
| T25 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T26 | 827-831 | gene:9839 | denotes | ZEB2 |
| T27 | 875-892 | disease:C2939419 | denotes | tumour metastasis |
| R1 | T0 | T1 | associated_with | ZEB1,tumour metastasis |
| R2 | T2 | T3 | associated_with | ZEB1,tumour metastasis |
| R3 | T4 | T5 | associated_with | deltaEF1,tumour metastasis |
| R4 | T6 | T7 | associated_with | deltaEF1,tumour metastasis |
| R5 | T8 | T9 | associated_with | SIP1,tumour metastasis |
| R6 | T10 | T11 | associated_with | SIP1,tumour metastasis |
| R7 | T12 | T13 | associated_with | SIP1,tumour metastasis |
| R8 | T14 | T15 | associated_with | SIP1,tumour metastasis |
| R9 | T16 | T17 | associated_with | SIP1,tumour metastasis |
| R10 | T18 | T19 | associated_with | SIP1,tumour metastasis |
| R11 | T20 | T21 | associated_with | SIP1,tumour metastasis |
| R12 | T22 | T23 | associated_with | SIP1,tumour metastasis |
| R13 | T24 | T25 | associated_with | ZEB2,tumour metastasis |
| R14 | T26 | T27 | associated_with | ZEB2,tumour metastasis |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 18376396-4#105#109#gene6935 | 773-777 | gene6935 | denotes | ZEB1 |
| 18376396-4#125#133#gene6935 | 793-801 | gene6935 | denotes | deltaEF1 |
| 18376396-4#139#143#gene8487 | 807-811 | gene8487 | denotes | SIP1 |
| 18376396-4#139#143#gene9169 | 807-811 | gene9169 | denotes | SIP1 |
| 18376396-4#139#143#gene9351 | 807-811 | gene9351 | denotes | SIP1 |
| 18376396-4#139#143#gene9839 | 807-811 | gene9839 | denotes | SIP1 |
| 18376396-4#159#163#gene9839 | 827-831 | gene9839 | denotes | ZEB2 |
| 18376396-4#207#224#diseaseC0027627 | 875-892 | diseaseC0027627 | denotes | tumour metastasis |
| 105#109#gene6935207#224#diseaseC0027627 | 18376396-4#105#109#gene6935 | 18376396-4#207#224#diseaseC0027627 | associated_with | ZEB1,tumour metastasis |
| 125#133#gene6935207#224#diseaseC0027627 | 18376396-4#125#133#gene6935 | 18376396-4#207#224#diseaseC0027627 | associated_with | deltaEF1,tumour metastasis |
| 139#143#gene8487207#224#diseaseC0027627 | 18376396-4#139#143#gene8487 | 18376396-4#207#224#diseaseC0027627 | associated_with | SIP1,tumour metastasis |
| 139#143#gene9169207#224#diseaseC0027627 | 18376396-4#139#143#gene9169 | 18376396-4#207#224#diseaseC0027627 | associated_with | SIP1,tumour metastasis |
| 139#143#gene9351207#224#diseaseC0027627 | 18376396-4#139#143#gene9351 | 18376396-4#207#224#diseaseC0027627 | associated_with | SIP1,tumour metastasis |
| 139#143#gene9839207#224#diseaseC0027627 | 18376396-4#139#143#gene9839 | 18376396-4#207#224#diseaseC0027627 | associated_with | SIP1,tumour metastasis |
| 159#163#gene9839207#224#diseaseC0027627 | 18376396-4#159#163#gene9839 | 18376396-4#207#224#diseaseC0027627 | associated_with | ZEB2,tumour metastasis |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1526 | 773-777 | gene:6935 | denotes | ZEB1 |
| T1527 | 875-892 | disease:C0027627 | denotes | tumour metastasis |
| T1528 | 793-801 | gene:6935 | denotes | deltaEF1 |
| T1529 | 807-811 | gene:8487 | denotes | SIP1 |
| T1530 | 827-831 | gene:9839 | denotes | ZEB2 |
| R1 | T1526 | T1527 | associated_with | ZEB1,tumour metastasis |
| R2 | T1528 | T1527 | associated_with | deltaEF1,tumour metastasis |
| R3 | T1529 | T1527 | associated_with | SIP1,tumour metastasis |
| R4 | T1529 | T1527 | associated_with | SIP1,tumour metastasis |
| R5 | T1529 | T1527 | associated_with | SIP1,tumour metastasis |
| R6 | T1529 | T1527 | associated_with | SIP1,tumour metastasis |
| R7 | T1530 | T1527 | associated_with | ZEB2,tumour metastasis |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 54-65 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T2 | 119-130 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T3 | 1061-1072 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T4 | 1089-1100 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T5 | 1272-1283 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T6 | 160-166 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T7 | 1242-1248 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T8 | 1368-1374 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 1242-1248 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T2 | 1368-1374 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T3 | 160-166 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T4 | 54-65 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T5 | 119-130 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T6 | 1061-1072 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T7 | 1089-1100 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T8 | 1272-1283 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |